PA
Par Drugs and Chemicals Limited
PAR.NS · NSE
₹141.08 +4.99% (+₹6.71)
1M +33.83%
Market Cap ₹2.01B
P/E Ratio 13.86x
Div. Yield -
ROE 13.68%
Bulios Fair Price
₹187.69
33.0% upside
Trenutna cena
₹141.08
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PAR.NS trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
78 /100
Cheap P/E 13.86x
EV/EBITDA 7.79x
P/S 1.85x
Growth
60 /100
Stable EPS growth 4.96%
Rev. growth 2.91%
FCF growth 36.07%
Profitability
69 /100
Strong Gross margin 50.75%
Net margin 13.31%
Op. margin 14.87%
Quality
67 /100
Excellent ROIC 10.61%
ROE 13.68%
ROA 11.22%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 4.68x
Int. coverage 150.02x
Stability
72 /100
Stable Beta 0.10x
Rev. volatility 2.51%
EPS volatility 19.15%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PAR.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Jignesh Vallabhbhai Savani
Employees
122
Headquarters
Vadodara